Comparing two types of radiotherapy for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial compares adaptive radiotherapy (which adjusts to changes in your body) with conventional radiotherapy for prostate cancer. It aims to see which approach leads to better patient-reported outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have prostate cancer and be scheduled for radiation therapy with the goal of curing it.
- You must be 18 years or older.
- You must be in good general health (able to carry out daily activities without help).
- You must be willing and able to use a health app on a smartphone or computer.
- You must be fluent in French, English, or Dutch.
- You cannot have had previous radiation therapy to the pelvic area or treatment for rectal or bladder cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a newer type of daily CT scan (CBCT-guided adaptive radiotherapy) can safely and accurately deliver radiation to cancers of the prostate, cervix, bladder, lung, or head and neck. The goal is to better target the tumor and reduce side effects.
This trial compares two standard treatment options—radiation or surgery—for people with high-risk prostate cancer that has not spread. The goal is to see which approach works better for long-term cancer control and side effects.
This trial compares two ways of giving radiation to the prostate and pelvic lymph nodes. It also tests two different instructions for how full your bladder should be during treatment. The goal is to see which approach works better and is easier for patients.
This study compares two ways of giving radiation to the prostate, including a “boost” using a special internal radiation treatment. It’s meant to see which radiation schedule works better and is safer for certain prostate cancer patients.
This trial tests a new way to deliver radiation therapy for prostate cancer using adaptive techniques—meaning the treatment adjusts based on imaging done right before each session. The goal is to safely give higher doses in fewer treatments, reducing your overall therapy time.
This trial tests a new type of radiation therapy that is customized for each patient's prostate cancer. The radiation targets the tumor more precisely, which may help reduce side effects while treating the cancer effectively.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.